Dultz, L. A., Dhar, S., Ogilvie, J. B., Heller, K. S., Bar-Sagi, D., & Patel, K. N. (2013). CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER.
Citação norma ChicagoDultz, Linda A., Shumon Dhar, Jennifer B. Ogilvie, Keith S. Heller, Dafna Bar-Sagi, and Kepal N. Patel. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.
MLA CitationDultz, Linda A., et al. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.